ORTX - Orchard Therapeutics GAAP EPS of -$0.12 revenue of $1.23M May, 15 2023 10:03 AM Orchard Therapeutics plc 2023-05-15 10:03:03 ET Orchard Therapeutics press release ( NASDAQ: ORTX ): Q1 GAAP EPS of -$0.12. Revenue of $1.23M (-77.7% Y/Y). For further details see: Orchard Therapeutics GAAP EPS of -$0.12, revenue of $1.23M